Table 1 Sociodemographic and clinical characteristics of 161 cancer patients included in the study
Characteristics | Patients in active treatment (n = 80) | Patients in palliative care/treatment (n = 81) | |||
|---|---|---|---|---|---|
N | % | N | % | p value | |
Sex | 0.134 | ||||
Men | 35 | 43.8 | 45 | 55.6 | |
Women | 45 | 56.3 | 36 | 44.4 | |
Age (years) | 0.830 | ||||
18–39 | 1 | 1.3 | 1 | 1.2 | |
40–49 | 11 | 13.8 | 7 | 8.6 | |
50–59 | 14 | 17.5 | 14 | 17.3 | |
60–69 | 20 | 25.0 | 22 | 27.2 | |
70–79 | 29 | 36.3 | 28 | 34.6 | |
80 + | 5 | 6.3 | 9 | 11.1 | |
Civil status | 0.116 | ||||
Single | 12 | 15.0 | 7 | 8.6 | |
Married /cohabiting | 65 | 81.3 | 65 | 80.2 | |
Other (widow/divorced/separated) | 3 | 3.8 | 9 | 11.1 | |
Residence | 0.305 | ||||
Private (flat, house, etc.) | 77 | 96.3 | 80 | 98.8 | |
Other (Nursing home, homeless, etc.) | 3 | 3.8 | 1 | 1.2 | |
Education | 0.477 | ||||
Primary education or lower | 9 | 11.3 | 6 | 7.4 | |
Secondary education | 28 | 35.0 | 35 | 43.2 | |
Higher education | 43 | 53.8 | 40 | 49.4 | |
Diagnosis (ICD-10) | 0.011 | ||||
Head and neck (C00-C14, C32) | 1 | 1.3 | 7 | 8.6 | |
Digestive system (C15-17 & C22 + 25) | 11 | 13.8 | 17 | 21.0 | |
Colorectal (C18-C20) | 15 | 18.8 | 10 | 12.3 | |
Lung (C33-C34) | 20 | 25.0 | 15 | 18.5 | |
Breast (C50) | 16 | 20.0 | 9 | 11.1 | |
Prostate (C61) | 4 | 5.0 | 1 | 1.2 | |
Multiple myeloma (C90) | 9 | 11.3 | 5 | 6.2 | |
Leukemia (C91-C95) | 1 | 1.3 | 5 | 6.2 | |
Other cancers (all other C codes) | 3 | 3.8 | 12 | 14.8 | |
Type of service | < 0.001 | ||||
Oncology department (or outpatient clinic) | 70 | 87.5 | 22 | 27.2 | |
Palliative care service | 0 | 0.0 | 49 | 60.5 | |
Internal medicine department | 10 | 12.5 | 10 | 12.3 | |
Patient status | 0.211 | ||||
Outpatient | 62 | 77.5 | 69 | 85.2 | |
Inpatient | 18 | 22.5 | 12 | 14.8 | |
Current treatment | < 0.001 | ||||
Palliative care (supportive care, symptom control, etc.) | 0 | 0.0 | 31 | 38.3 | |
Chemotherapy | 34 | 42.5 | 24 | 29.6 | |
Endocrine therapy | 4 | 5.0 | 2 | 2.5 | |
Immunotherapy | 12 | 15.0 | 16 | 19.8 | |
Radiation therapy | 10 | 12.5 | 0 | 0.0 | |
Targeted therapy | 6 | 7.5 | 2 | 2.5 | |
Combination strategies (chemotherapy + radiation, targeted therapy or immunotherapy) | 14 | 17.5 | 6 | 7.4 | |
Country | 0.824 | ||||
Austria | 10 | 12.5 | 10 | 12.3 | |
Chile | 10 | 12.5 | 10 | 12.3 | |
France | 10 | 12.5 | 10 | 12.3 | |
Jordan | 9 | 11.3 | 12 | 14.8 | |
Netherlands | 9 | 11.3 | 10 | 12.3 | |
Norway | 8 | 10.0 | 12 | 14.8 | |
Spain | 10 | 12.5 | 10 | 12.3 | |
United Kingdom | 14 | 17.5 | 7 | 8.6 | |